智利大学的研究人员已研制出世界首例酒瘾疫苗。这种疫苗注射入体内后,酒瘾患者浅酌一口便能立即产生心跳加速、恶心等宿醉症状,令其痛苦不堪。研究人员表示,将从2月起用该疫苗在老鼠身上进行临床前试验,人体试验将在11月进行。据介绍,该疫苗在体内有效期至少为6个月,且注射后产生的反应无法人为消除。研究人员预计,注射疫苗后,当地的酒类消费量有望下降90%。世界卫生组织2011年的数据显示,酒精是世界第三大致病和致残危险因素,每年因酗酒导致的死亡人数为250万。
While past research has proffered potential treatments for alcoholism, scientists have yet to develop a working vaccine to treat the maladaptive pattern of drinking.
However, that may all change if researchers at the University of Chile are successful. In February, a team of scientists is set to begin preclinical trials for the world's first alcoholism vaccine, the Santiago Times reports.
The vaccine delivers somewhat of an instant hangover if the patient takes one sip of alcohol. Researchers will first test the vaccine on mice; human trials are set for November.
"If it works, it's going to have a worldwide impact, but with many vaccines one has to test them carefully." Dr. Juan Asenjo, director of the university's Institute for Cell Dynamics and Biotechnology, told the Santiago Times. "I think the chances that this one will work are quite high."
【智利科学家研发世界首例酒瘾疫苗】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15